Comparison results
| Results: Differences General | ✘Chronic monocytic leukemia | ✘Erythroplasia of Keira | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 92% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 58% | ||||||||||
| lowered | 62% | — | ||||||||||
| bowen's disease | — | 54% | ||||||||||
| acute leukemia | 61% | — | ||||||||||
| leukocyturia | — | 53% | ||||||||||
| monocytosis | 57% | — | ||||||||||
| proteinuria | — | 47% | ||||||||||
| professional cancer | 48% | — | ||||||||||
| cancer of the mucous membranes of the mouth | — | 46% | ||||||||||
| thrombocytopenia | 36% | — | ||||||||||
| epithelioma | — | 42% | ||||||||||
| erythrocytic anemia | 34% | — | ||||||||||
| penile cancer | — | 37% | ||||||||||
| waldenstrom 's macroglobulinemia | 34% | — | ||||||||||
| skin cancer | — | 36% | ||||||||||
| chronic leukemia | 33% | — | ||||||||||
| genital neoplasms | — | 36% | ||||||||||
| chronic myeloid leukemia | 31% | — | ||||||||||
| squamous cell carcinoma | — | 34% | ||||||||||
| increased gamma globulins | 29% | — | ||||||||||
| operations in the oral cavity | — | 31% | ||||||||||
| subacute condition | 26% | — | ||||||||||
| hyperemia of genitals | — | 28% | ||||||||||
| hemorrhagic syndrome | 26% | — | ||||||||||
| precancer | — | 27% | ||||||||||
| leukemia | 26% | — | ||||||||||
| basal | — | 27% | ||||||||||
| hepatosplenomegaly | 23% | — | ||||||||||
| carcinoid | — | 27% | ||||||||||
| enlargement of the liver and spleen | 23% | — | ||||||||||
| inflammation of the glans penis | — | 26% | ||||||||||
| anemia | 22% | — | ||||||||||
| oncology | — | 26% | ||||||||||
| very correct | 22% | — | ||||||||||
| skin problems | — | 26% | ||||||||||
| chronic anemia | 22% | — | ||||||||||
| history of surgery | — | 25% | ||||||||||
| enlargement of the spleen | 22% | — | ||||||||||
| balanoposthitis in boys | — | 23% | ||||||||||
| increased ESR | 22% | — | ||||||||||
| clear boundaries | — | 22% | ||||||||||
| enlarged liver | 20% | — | ||||||||||
| lot of operations in small things | — | 21% | ||||||||||
| tuberculosis | 20% | — | ||||||||||
| lymphosarcoma | — | 21% | ||||||||||
| leukocytosis | 20% | — | ||||||||||
| a lot of medicines | — | 20% | ||||||||||
| blood diseases | 33% | 12% | ||||||||||
| dry | — | 19% | ||||||||||
| feeling of heat | 18% | — | ||||||||||
| at night 2 4 times | — | 18% | ||||||||||
| high temperature | 18% | — | ||||||||||
| stomatitis | — | 18% | ||||||||||
| increased | 31% | 11% | ||||||||||
| skin overgrowth | — | 17% | ||||||||||
| childhood diseases | 17% | — | ||||||||||
| hair loss | — | 17% | ||||||||||
| metastases | 23% | 15% | ||||||||||
| hyperpigmentation | — | 17% | ||||||||||
| more often in old age | 23% | 17% | ||||||||||
| drug disease | — | 17% | ||||||||||
| reddening of the skin | — | 15% | ||||||||||
| dermatitis | — | 15% | ||||||||||
| lymph node damage | — | 15% | ||||||||||
| radiation damage | — | 14% | ||||||||||
| suspicion | — | 14% | ||||||||||
| radiation therapy | — | 14% | ||||||||||
| pneumonia | — | 14% | ||||||||||
| gradual deterioration of the condition | — | 14% | ||||||||||
| nausea | — | 13% | ||||||||||
| necrosis | — | 13% | ||||||||||
| bleeding | — | 13% | ||||||||||
| consequences of taking medications | — | 12% | ||||||||||
| patient's condition | — | 11% | ||||||||||
| cancer | 21% | 28% | ||||||||||
| hyperchromia | 100% | 100% | ||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
